FX Empire64d agoneutral
New Cholesterol Pill, Earnings Growth Boost Merck SharesShares of Merck & Co., Inc. (MRK) rise 3,453% since 1990 thanks to institutional investors.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
63last 24h
973last 7d
109● bullish (7d)
123● bearish (7d)
212publishers
Barchart67d agoneutral
Earnings Preview: What To Expect From Merck & Co.'s ReportMerck & Co. is expected to announce its second-quarter earnings in August, and Wall Street forecasts a double-digit decline in its profits.
Investor's Business Daily75d agobullish
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into EarningsJohnson & Johnson stock is Monday's IBD Stock Of The Day. The medical bellwether will report its June-quarter earnings next week.
Yahoo Finance Video85d agobearishVIDEO
Big Tech stocks tumble while Micron continues to gain on Q3 earningsUS stocks (^DJI, ^IXIC, ^GSPC) search for direction ahead of Thursday's session close, while Micron Technology (MU) holds onto gains following its massive earnings beat yesterday. Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the day's market moves, Big Tech stocks, and how Micron's stock gains may be impacting Apple (AAPL).
Zacks100d agoneutral
Is PAHC Undervalued at 10x Earnings vs Peers?Phibro trades near 10x forward earnings vs higher peer multiples as strong Q3 beat, margin gains and 2026 guidance support a modest upside case.
Zacks107d agoneutral
Why Is Pfizer (PFE) Down 4.5% Since Last Earnings Report?Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Proactive107d agoneutral
Nasdaq set to drop after Broadcom, Crowdstrike earnings, Dow Jones called higherUS stocks were expected to head in different directions on Thursday morning, as oil prices retreat but tech earnings overnight disappointed investors. Dow Jones futures were called 0.8% higher, but the S&P 500 was off 0.4% and Nasdaq futures were down 1.3%. The latter pair were...
MarketBeat129d agoneutral
Merck KGaA Q1 Earnings Call HighlightsMerck KGaA (ETR:MRK) reported what executives described as a “solid start” to 2026, with organic growth in its Life Science and Electronics businesses offsetting a decline in Healthcare, and raised its full-year outlook after stronger momentum late in the quarter. Group Chief Executive Officer Kai
The Wall Street Journal129d agobullish
Germany’s Merck KGaA Raises GuidanceThe outlook lift comes on expectations of stronger momentum in the group’s life-sciences unit, resilience in healthcare, as well as its first-quarter performance and market conditions.
Moby134d agoneutral
Codexis, Inc. Q1 2026 Earnings Call SummaryMoby summary of Codexis, Inc.'s Q1 2026 earnings call
MarketBeat134d agoneutral
Codexis Q1 Earnings Call HighlightsCodexis (NASDAQ:CDXS) reported first-quarter 2026 revenue of $15.2 million, up from $7.5 million a year earlier, as the company highlighted continued progress commercializing its ECO Synthesis enzymatic manufacturing platform for RNA medicines and reiterated full-year revenue guidance of $72 million